Diabetes, Vol 46, Issue 11 1868-1874, Copyright © 1997 by American Diabetes Association

ARTICLES

Renal and ocular hemodynamic effects of insulin

L Schmetterer, M Muller, P Fasching, C Diepolder, A Gallenkamp, G Zanaschka, O Findl, K Strenn, C Mensik, E Tschernko, HG Eichler and M Wolzt
Department of Clinical Pharmacology, Institute of Medical Physics, Vienna University School of Medicine, Austria.

There is evidence that the vasodilator action of insulin is mediated by the release of nitric oxide (NO). We hypothesized that euglycemic hyperinsulinemia might increase renal and ocular blood flow, and that the vasodilator capacity of insulin might be NO-dependent. Euglycemic insulin clamps were performed in 10 healthy subjects. Sixty minutes after the start of insulin administration, an intravenous coinfusion of N-monomethyl-L-arginine (L-NMMA), an inhibitor of NO synthase, or of norepinephrine (NE), an endothelium-independent vasoconstrictor, was started. Renal plasma flow was measured by para-aminohippurate (PAH) clearance method. Ocular hemodynamics were assessed by laser interferometric measurement of fundus pulsations and Doppler sonographic measurement of blood flow velocity in the ophthalmic artery. Renal plasma flow and ocular fundus pulsations were increased by insulin. L-NMMA almost completely abolished the vasodilative effects of insulin, whereas the effects of combined infusion of insulin and NE were approximately the sum of the hemodynamic changes induced by each agent alone. The results show that during euglycemic hyperinsulinemia, renal and ocular blood flow are increased, which may be mediated either by a local vasodilator effect or a systemic increase in flow. The hemodynamic effects of insulin in the kidney and the eye are at least partially dependent on NO synthesis. Because the insulin plasma levels we obtained are in the high physiological range, it may be assumed that insulin plays a role in renal and ocular blood flow regulation.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				J. Zdychova, L. Kazdova, T. Pelikanova, J. N. Lindsley, S. Anderson, and R. Komers Renal Activity of Akt Kinase in Obese Zucker Rats Experimental Biology and Medicine, October 1, 2008; 233(10): 1231 - 1241. [Abstract] [Full Text] [PDF]

				K.-H. Huemer, G. Garhofer, T. Aggermann, J. Kolodjaschna, L. Schmetterer, and G. Fuchsjager-Mayrl Role of Nitric Oxide in Choroidal Blood Flow Regulation during Light/Dark Transitions Invest. Ophthalmol. Vis. Sci., September 1, 2007; 48(9): 4215 - 4219. [Abstract] [Full Text] [PDF]

				T. S. Perlstein, M. Gerhard-Herman, N. K. Hollenberg, G. H. Williams, and A. Thomas Insulin Induces Renal Vasodilation, Increases Plasma Renin Activity, and Sensitizes the Renal Vasculature to Angiotensin Receptor Blockade in Healthy Subjects J. Am. Soc. Nephrol., March 1, 2007; 18(3): 944 - 951. [Abstract] [Full Text] [PDF]

				A. Rab, S. Dallinger, K. Polak, J. Pleiner, E. Polska, M. Wolzt, and L. Schmetterer Specific Endothelin ETA Receptor Antagonism Does Not Modulate Insulin-Induced Hemodynamic Effects in the Human Kidney, Eye, or Forearm J. Pharmacol. Exp. Ther., May 1, 2004; 309(2): 692 - 696. [Abstract] [Full Text] [PDF]

				G. T. Dorner, G. Garhofer, K.-H. Huemer, E. Golestani, C. Zawinka, L. Schmetterer, and M. Wolzt Effects of Adrenomedullin on Ocular Hemodynamic Parameters in the Choroid and the Ophthalmic Artery Invest. Ophthalmol. Vis. Sci., September 1, 2003; 44(9): 3947 - 3951. [Abstract] [Full Text] [PDF]

				G. T. Dorner, G. Garhofer, B. Kiss, E. Polska, K. Polak, C. E. Riva, and L. Schmetterer Nitric oxide regulates retinal vascular tone in humans Am J Physiol Heart Circ Physiol, July 11, 2003; 285(2): H631 - H636. [Abstract] [Full Text] [PDF]

				S. Dallinger, A. Sieder, J. Strametz, M. Bayerle-Eder, M. Wolzt, and L. Schmetterer Vasodilator effects of L-arginine are stereospecific and augmented by insulin in humans Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1106 - E1111. [Abstract] [Full Text] [PDF]

				A. Luksch, K. Polak, C. Beier, E. Polska, M. Wolzt, G. T. Dorner, H.-G. Eichler, and L. Schmetterer Effects of Systemic NO Synthase Inhibition on Choroidal and Optic Nerve Head Blood Flow in Healthy Subjects Invest. Ophthalmol. Vis. Sci., September 1, 2000; 41(10): 3080 - 3084. [Abstract] [Full Text]

				M. Bayerle-Eder, M. Wolzt, E. Polska, H. Langenberger, J. Pleiner, D. Teherani, G. Rainer, K. Polak, H.-G. Eichler, and L. Schmetterer Hypercapnia-induced cerebral and ocular vasodilation is not altered by glibenclamide in humans Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2000; 278(6): R1667 - R1673. [Abstract] [Full Text] [PDF]

				B. Jilma, S. Dallinger, N. Hergovich, H.-G. Eichler, V. Richter, and O. F. Wagner Effects of Hyperinsulinemia on Plasma Levels of Circulating Adhesion Molecules J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1748 - 1751. [Abstract] [Full Text]

				K. Polak, S. Dallinger, E. Polska, O. Findl, H.-G. Eichler, M. Wolzt, and L. Schmetterer Effects of Insulin on Retinal and Pulsatile Choroidal Blood Flow in Humans Arch Ophthalmol, January 1, 2000; 118(1): 55 - 59. [Abstract] [Full Text] [PDF]

				T. Kawagishi, M. Matsuyoshi, M. Emoto, H. Taniwaki, H. Kanda, Y. Okuno, M. Inaba, E. Ishimura, Y. Nishizawa, and H. Morii Impaired Endothelium-Dependent Vascular Responses of Retinal and Intrarenal Arteries in Patients With Type 2 Diabetes Arterioscler. Thromb. Vasc. Biol., October 1, 1999; 19(10): 2509 - 2516. [Abstract] [Full Text] [PDF]